Abstract
Purpose of Review
This review provides a short overview on the role of Bacillus cereus group organisms as foodborne pathogens and summarizes the current scientific knowledge on B. cereus as causative agent of non-gastrointestinal diseases.
Recent Findings
B. cereus is a well-known causative agent of foodborne bacterial intoxications in particular linked to the restaurant and catering sector. This endospore forming bacteria can cause two different types of foodborne illness, the emetic and the diarrheic syndrome, which are usually self-limiting. However, severe intoxications, requiring hospitalization and including even fatalities, are on a rise. Furthermore, B. cereus is also increasingly reported as causative agent of non-gastrointestinal diseases, especially in clinical settings.
Summary
Over the last decades, substantial progress has been made in understanding the role of B. cereus in foodborne outbreaks, while information on non-gastrointestinal diseases, often linked to hospital acquired infections, caused by B. cereus is rather limited.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The Bacillus (B.) cereus group, a subdivision of the genus “Bacillus” also known as “Bacillus cereus sensu lato (s.l.),” comprises a growing list of genetically closely related Gram-positive, spore-forming bacterial species. The most prominent members are as follows: B. anthracis, B. cereus sensu stricto (s.s.), B. thuringiensis, B. weihenstephanensis, B. mycoides, B. pseudomycoides, B. cytotoxicus, and B. toyonensis. Members of the B. cereus group are widely distributed in diverse environments worldwide. They can grow under highly variable conditions (aerobic as well as anaerobic) over a broad temperature range. Due to the formation of endospores highly resistant to heat, pH, and desiccation, they are hard to inactivate and eradicate from food production and processing chains as well as from clinical settings. The pathogenic potential of B. cereus s.l. is quite variable, ranging from strains used as plant growth promoter and biopesticides to strains causing fatal diseases.
B. cereus is well known as important foodborne pathogen, which can cause two different types of gastrointestinal (GI) diseases: the emetic and the diarrheal syndrome. The emetic form of B. cereus food poisoning, resembling Staphylococcus aureus intoxications, is caused by cereulide, a small heat stable depsipeptide that is (pre-) formed directly in the food matrix. The emetic syndrome is characterized by nausea and vomiting 0.5 to 6 h after consumption of contaminated food. Usually, symptoms last not more than 1 day, but occasionally, hospitalization is required and intoxications with fatal outcomes are increasingly reported (reviewed in [1, 2]). Severe intoxications can lead to acute liver failure and encephalopathy [3, 4]. Recently, several isoforms of the cereulide toxin have been described, including one isoform showing tenfold cytotoxicity of the known cereulide in vitro [5]. These isoforms are produced under food production and processing conditions, but their exact contribution to intoxications still needs to be elucidated [6, 7•]. Furthermore, results from in vitro studies using low levels of cereulide suggest a potential role of cereulide in the induction of diabetes [8]. Thus, even subemetic doses of cereulide may pose a risk, which needs to be studied in more detail. The symptoms of the diarrheal form of B. cereus food poisoning, which is characterized by abdominal pain and watery diarrhea, resemble the symptoms of a Clostridium perfringens infection. In contrast to the emetic toxin, the diarrhea-associated enterotoxins are not produced in the food matrix itself, but in the intestine, upon ingestion of the toxin-producing B. cereus strains with the food. Two tripartite protein toxin complexes, the non-hemolytic enterotoxin complex (Nhe) and the hemolytic enterotoxin complex (Hbl), and the single protein cytotoxin K (CytK) have been linked to the diarrheal syndrome. In addition, several other virulence factors have been discussed, which may contribute to the enterotoxicity of B. cereus group strains (for review, see [9]). For instance, it has been shown in vitro and in vivo that the sphingomyelinase (SMase) of B. cereus synergistically interacts with Nhe as well as with Hbl; thus, it is tempting to speculate that SMase contributes to the severity of the disease [10, 11]. However, further studies are necessary to decipher the exact role of SMase and other putative virulence factors in B. cereus pathogenicity.
Besides its potential to cause gastrointestinal diseases, members of the B. cereus group are increasingly linked to nosocomial non-gastrointestinal infections. Usually, these diseases are associated with immunosuppression of the affected patient, but there are also cases reported from immunocompetent persons. The extraintestinal diseases caused by members of the B. cereus group range from local (eye infections, traumatic and surgical wound infections) to systematic infections, e.g., fulminant septicemia [12]. The virulence factors contributing to non-gastrointestinal infections are largely unknown, and the role of the known, GI-associated toxins in non-gastrointestinal infections is still cryptic.
Members of the Bacillus cereus Group as Foodborne Pathogens
In the European Union (EU), every year 500 to 700 confirmed human cases of foodborne diseases caused by B. cereus s.l. are reported (see Fig. 1). In 2016, bacterial toxins ranked second among the causative agents in foodborne and waterborne outbreaks, and 17.7% of the reported foodborne outbreaks were caused by bacterial toxins, including B. cereus emetic and diarrheal toxins [13]. Concerning the food matrices, involved in these outbreak situations, “mixed food” was reported in 23%, “other food” in 17%, and “cereal products and legumes” in 14% of the outbreaks [13]. In routine diagnostics, the members of the B. cereus group will not be differentiated; instead, the whole group will be identified as B. cereus s.l. (formally called presumptive B. cereus). Thus, the numbers of outbreaks reported, including the ones shown in Fig. 1, usually refer to B. cereus s.l. (Fig. 1).
Even though the number of reported outbreaks and illnesses caused by members of the B. cereus group is increasing over the last decade, the true incidence of B. cereus food poisoning is still unknown for a number of reasons, including misdiagnosis of the illness, which may be symptomatically similar to other types of food poisoning and diagnostic deficiencies with regard to this foodborne pathogen, both in clinical and food microbiology [14]. So far, diagnostics of the B. cereus group are mainly based on phenotypic characteristics. However, in the light of consumer protection, it is expected that in the future, the focus will move toward risk-orientated differential diagnostics by including methods for detection of toxins, toxin genes, and virulence markers. Indeed, in the context of foodborne outbreak investigations, molecular typing and toxin gene profiling are already of much higher importance than the differentiation between the species of the B. cereus group (for review, see [15]). The cytotoxin K exists in two variants, cytotoxin K1 (CytK-1) and cytotoxin K2 (CytK-2). CytK-1 is a highly potent toxin that is restricted to a very distinct group of B. cereus s.l. strains, which was recently reclassified to B. cytotoxicus [16]. In contrast, the CytK-2 protein, which is found frequently among B. cereus group members, exhibits only one fifth of the toxicity of the CytK-1 protein in vitro [17], thus putting into question its role as bona fide toxin in foodborne illness [18, 19•]. Thus, for the investigation of foodborne outbreaks linked to B. cereus s.l., the molecular differentiation of the two variants of CytK is essential for a correct indication of the possible virulence of the detected strains.
The emetic toxin cereulide is found in a specific subgroup of B. cereus s.s., while the enterotoxin genes and other virulence factors are broadly distributed among the members of the B. cereus. It is assumed that Nhe is produced by 91 to 100% of B. cereus s.s. and also by other B. cereus group species, such as B. thuringiensis and B. weihenstephanensis. The ability for Hbl production was found in 44 to 60% of the B. cereus s.s. and also in other B. cereus species such as B. thuringiensis and B. weihenstephanensis [9, 20, 21]. Frequently, isolates possess the ability to produce not only one but also two or more enterotoxins [22]. In this context, the current discussion about the safety of B. thuringiensis, which is widely used as biopesticide, should be considered [23•]. Several B. thuringiensis strains are able to produce the two enterotoxin complexes Nhe and HBL, which are known to play a pivotal role in the diarrheal syndrome. Therefore, it would be of utmost importance to gather more data on the occurrence of toxin producing B. thuringiensis strains in foods and in foodborne outbreaks to assess the actual risk related to the increasing use of B. thuringiensis as biopesticide and B. thuringiensis contaminations in foods. The use of B. thuringiensis as biopesticide might have no substantial impact on human health. However, due to the lack of data, it cannot be ruled out that B. thuringiensis plays a much more greater risk for human health than currently assumed [23•]. Thus, novel risk-orientated diagnostic tools, including (apart from the known toxins) additional virulence markers, will be necessary to close the current gap of data and pave the way for evidence-based decision-making regarding the risk potential related to a certain B. cereus group strain.
Non-Gastrointestinal Diseases Caused by Members of the Bacillus cereus Group
In addition to the well-known role of B. cereus group members in foodborne gastrointestinal infections or intoxications, these organisms can also cause a wide range of extraintestinal diseases. This is primarily the case in immunocompromised persons, but reports of B. cereus infections from immunocompetent persons are on a rise. In contrast to the foodborne diseases linked to B. cereus, the key virulence determinant of extraintestinal diseases is largely unknown, although a panoply of potential virulence factors of B. cereus has been described [24]. Using a mouse model, it could be shown that B. cereus sphingomyelinase is a crucial factor in the outcome of septicemia [25], and in vitro studies suggest an essential role of the immune inhibitor protein A in macrophage escape [26]. Nevertheless, substantial research will be necessary to fully unravel the role of the different virulence factors in the growing list of extraintestinal diseases linked to B. cereus infections.
The most relevant risks factors for an extraintestinal B. cereus infection in immunocompromised patients are:
-
Intravenous drug abuse
-
Indwelling catheters
-
Traumatic or surgical wounds
-
Leukemia
In addition, extraintestinal B. cereus infections are found frequently in premature infants. The spectrum of symptoms related to non-gastrointestinal B. cereus infections depends on the port of entry and ranges from gas gangrene-like cutaneous infections, endophthalmitis, and pneumonia to fulminant bacteremia, including meningitis and brain abscesses [12]. Based on case reports of recent years (see Table 1), extraintestinal infections caused by members of the B. cereus group can be split in the following groups:
-
Systemic infections (bacteremia and septicemia)
-
Infections in the eye area (panophthalmitis, endophthalmitis)
-
Infections in the brain area (brain abscess, meningoencephalitis)
-
Infections in the heart area (endocarditis)
Similar to foodborne gastrointestinal diseases caused by members of the B. cereus group, the true incidence of non-gastrointestinal B. cereus diseases is unknown most probably underreported for several reasons. One reason might be that in medical microbiology, members of the B. cereus group are generally rather considered a “laboratory” or “environmental contamination” than a causative pathogenic agent. This is particularly the case when B. cereus s.l. is isolated from open wounds or from blood cultures. Usually, these bacteria are not further differentiated and toxin profiles are not determined routinely. Furthermore, most often, the strains are not kept for sequencing and genetic subtyping at a later stage. Thus, not only the true incidence but also the source of the strains and the pathophysiological mechanisms of the infections are largely unknown. This general lack of information from differential diagnostics is also reflected in the case reports from the last 5 years listed in Table 1. Furthermore, as shown recently, antibiotic treatment can induce the formation of small colony variants (SCVs) of B. cereus, which are at risk of misdiagnosis due to their altered metabolism and slow growth [51].
In principle, non-gastrointestinal infections caused by members of the B. cereus group can be divided in two categories: exogenous, originating from entry of the bacteria through a trauma, an open wound, or a medical intervention; or endogenous. In case of an exogenous entry, the source of infection can be normally detected, and in case of an endogenous entry, the source mostly remains unclear except for patients with a clear history of intravenous drug abuse. In some cases, there are indications that also non-gastrointestinal B. cereus infections could be traced back to contaminated food. In one case report from 2015, bananas were considered as a possible food source of five cases of progressive, hemorrhagic meningoencephalitis caused by B. cereus in patients with acute myeloid leukemia [32•]. Therefore, there is the possibility that also non-gastrointestinal infections caused by members of the B. cereus group can be food-related diseases.
Conclusion
Members of the B. cereus group are well-known opportunistic human pathogens, which can cause two different types of foodborne illnesses, emesis and diarrhea. Although the three main diarrhea-associated toxins, Nhe, HBL, and CytK, as well as the emetic toxin cereulide, are known over a decade and considerable progress has been made on the understanding of toxin gene regulation, the exact mechanisms of toxin syntheses and toxin actions are far from understanding. Furthermore, it becomes increasingly evident that additional virulence factors, such as SMase, could contribute to the pathogenicity of certain strains and the severity of the illness. Hitherto, a suitable animal model has neither been established for studying the mechanisms of B. cereus enterotoxicity nor translocation, potential metabolization or mechanisms of cereulide toxicity within the host in detail. Such models would also be of special importance to assess the actual risk of foodborne infections related to a particular B. cereus s.l. strain.
Besides the classical known foodborne infections and intoxications, members of the B. cereus group can also cause extraintestinal infections in both immunocompromised and immunocompetent patients. The source of these infections remains often unclear, partially due to a lack of awareness of the multifaceted role of B. cereus in a variety of local and systemic diseases and partially due to the limited information currently available on mechanisms of B. cereus pathogenicity.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Ehling-Schulz M, Fricker M, Scherer S. Bacillus cereus, the causative agent of an emetic type of food-borne illness. Mol Nutr Food Res. 2004;48:479–87.
Ehling-Schulz M, Messelhäusser U, Granum PE. Bacillus cereus in milk and dairy production. In: Hoorfar J, editor. Rapid detection, characterization and enumeration of food-borne pathogens. Washington D.C.: ASM Press; 2011. p. 275–89.
Dierick K, Van Coillie E, Swiecicka I, Meyfroidt G, Devlieger H, Meulemans A, et al. Fatal family outbreak of Bacillus cereus-associated food poisoning. J Clin Microbiol. 2005;43:4277–9.
Ichikawa K, Gakumazawa M, Inaba A, Shiga K, Takeshita S, Mori M, et al. Acute encephalopathy of Bacillus cereus mimicking Reye syndrome. Brain and Development. 2010;32(8):688–90. https://doi.org/10.1016/j.braindev.2009.09.004.
Marxen S, Stark TD, Frenzel E, Rutschle A, Lucking G, Purstinger G, et al. Chemodiversity of cereulide, the emetic toxin of Bacillus cereus. Anal Bioanal Chem. 2015;407:2439–53.
Kranzler M, Stollewerk K, Rouzeau-Szynalski K, Blayo L, Sulyok M, Ehling-Schulz M. Temperature exerts control of Bacillus cereus emetic toxin production on post-transcriptional levels. Front Microbiol. 2016;7:1640.
• Ehling-Schulz M, Frenzel E, Gohar M. Food-bacteria interplay: pathometabolism of emetic Bacillus cereus. Front Microbiol. 2015;6:704. https://doi.org/10.3389/fmicb.2015.00704. This review provides a comprehensive summary of the data available on the complex regulatory network controlling cereulide toxin synthesis and the role of intrinsic and extrinsic factors acting on toxin biosynthesis in emetic B . cereus .
Vangoitsenhoven R, Rondas D, Crevecoeur I, D'Hertog W, Baatsen P, Masini M, et al. Foodborne cereulide causes beta-cell dysfunction and apoptosis. PLoS One. 2014;9:e104866.
Stenfors Arnesen LP, Fagerlund A, Granum PE. From soil to gut: Bacillus cereus and its food poisoning toxins. FEMS Microbiol Rev. 2008;32:579–606.
Beecher DJ, Wong AC. Cooperative, synergistic and antagonistic haemolytic interactions between haemolysin BL, phosphatidylcholine phospholipase C and sphingomyelinase from Bacillus cereus. Microbiology. 2000;146(Pt 12):3033–9.
Doll VM, Ehling-Schulz M, Vogelmann R. Concerted action of sphingomyelinase and non-hemolytic enterotoxin in pathogenic Bacillus cereus. PLoS One. 2013;8:e61404.
Bottone EJ. Bacillus cereus, a volatile human pathogen. Clin Microbiol Rev. 2010;23:382–438.
EFSA (European Food Safety Authority) and ECDC (European Centre for Disease Prevention and Control). The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2016. EFSA J. 2017;15(12):5077, 228 pp. https://doi.org/10.2903/j.efsa.2017.5077.
Fricker M, Reissbrodt R, Ehling- Schulz M. Evaluation of standard and new chromogenic selective plating media for isolation and identification of Bacillus cereus. Int J Food Microbiol. 2008;121:27–34.
Ehling-Schulz M, Messelhausser U. Bacillus “next generation” diagnostics: moving from detection toward subtyping and risk-related strain profiling. Front Microbiol. 2013;4:32.
Guinebretiere MH, Auger S, Galleron N, Contzen M, De Sarrau B, De Buyser ML, et al. Bacillus cytotoxicus sp. nov. is a novelthermotolerant species of the Bacillus cereus group occasionally associated with food poisoning. Int J Syst Evol Microbiol. 2013;63:31–40.
Fagerlund A, Ween O, Lund T, Hardy SP, Granum PE. Genetic and functional analysis of the cytK family of genes in Bacillus cereus. Microbiology. 2004;150:2689–97.
Castiaux V, Liu X, Delbrassinne L, Mahillon J. Is cytotoxin K from Bacillus cereus a bona fide enterotoxin? Int J Food Microbiol. 2015;211:79–85.
• Jessberger N, Krey VM, Rademacher C, Bohm ME, Mohr AK, Ehling-Schulz M, et al. From genome to toxicity: a combinatory approach highlights the complexity of enterotoxin production in Bacillus cereus. Front Microbiol. 2015;6:560. In this study, comprehensive analyses of enterotoxin gene sequences, transcription, toxin secretion, and cytotoxicity were performed. For the first time, these parameters were compared in a whole set of B . cereus strains, representing isolates of different origins and of different toxic potentials, to decipher the basis of strain-specific differential toxicity.
Ehling-Schulz M, Knutsson R, Scherer S. In: Fratamico P, Kathariou S, Liu Y, editors. “Bacillus cereus” in Genomes of food- and water-borne pathogens. Washington D.C.: ASM Press; 2011. p. 147–64.
Pruss BM, Dietrich R, Nibler B, Martlbauer E, Scherer S. The hemolytic enterotoxin HBL is broadly distributed among species of the Bacillus cereus group. Appl Environ Microbiol. 1999;65:5436–42.
Ehling-Schulz M, Guinebretiere MH, Monthan A, Berge O, Fricker M, Svensson B. Toxin gene profiling of enterotoxic and emetic Bacillus cereus. FEMS Microbiol Lett. 2006;260:232–40.
• EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), 2016. Scientific opinion on the risks for public health related to the presence of Bacillus cereus and other Bacillus spp. including Bacillus thuringiensis in foodstuffs. EFSA J;14(7):4524, 93 pp. https://doi.org/10.2903/j.efsa.2016.4524. The scientific opinion of EFSA summarizes the latest scientific knowledge about bacteria of the B . cereus group and their significance for public health.
Schoeni JL, Wong AC. Bacillus cereus food poisoning and its toxins. J Food Prot. 2005;68:636–48.
Oda M, Hashimoto M, Takahashi M, Ohmae Y, Seike S, Kato R, et al. Role of sphingomyelinase in infectious diseases caused by Bacillus cereus. PLoS One. 2012;7:e38054.
Guillemet E, Cadot C, Tran SL, Guinebretiere MH, Lereclus D, Ramarao N. The InhA metalloproteases of Bacillus cereus contribute concomitantly to virulence. J Bacteriol. 2010;192:286–94.
Cheng VCC, Chen JHK, Leung SSM, So SYC, Wong SC, Wong SCY, et al. Seasonal outbreak of Bacillus bacteremia associated with contaminated linen in Hong Kong. Clin Infect Dis. 2017;64(suppl_2):S91–7. https://doi.org/10.1093/cid/cix044.
Saigal K, Gautam V, Singh G, Ray P. Bacillus cereus causing intratumoral brain abscess. Indian J Pathol Microbiol. 2016;59(4):554–6. https://doi.org/10.4103/0377-4929.191799.
Wright WF. Central venous access device-related Bacillus cereus endocarditis: a case report and review of the literature. Clin Med Res. 2016;14(2):109–15. https://doi.org/10.3121/cmr.2016.1312.
Magnussen ET, Vang AG, á Steig T, Gaini S. Relapsing peritonitis with Bacillus cereus in a patient on continuous ambulatory peritoneal dialysis. BMJ Case Rep. 2016; https://doi.org/10.1136/bcr-2015-212619.
Schaefer G, Campbell W, Jenks J, Beesley C, Katsivas T, Hoffmaster A, et al. Persistent Bacillus cereus bacteremia in 3 persons who inject drugs, San Diego, California, USA. Emerg Infect Dis. 2016;22(9):1621–3. https://doi.org/10.3201/eid2209.150647.
• Vodopivec I, Rinehart EM, Griffin GK, Johncilla ME, Pecora N, Yokoe DS, et al. A cluster of CNS infections due to B. cereus in the setting of acute myeloid leukemia: Neuropathology in 5 Patients. J Neuropathol Exp Neurol. 2015;74(10):1000–11. https://doi.org/10.1097/NEN.0000000000000244. This case study provides an example of a potential link between non-gastrointestinal infections caused by members of the B . cereus group and foodborne diseases.
Dabscheck G, Silverman L, Ullrich NJ. Bacillus cereus cerebral abscess during induction chemotherapy for childhood acute leukemia. J Pediatr Hematol Oncol. 2015;37(7):568–9. https://doi.org/10.1097/MPH.0000000000000413.
Sharma R, Rao R. Bacillus cereus bacteraemia in a patient of acute myeloid leukaemia. Indian J Med Microbiol. 2015;33(Suppl S1):168–70. Available from: http://www.ijmm.org/text.asp?2015/33/5/168/150982
Lam KC. Endophthalmitis caused by Bacillus cereus: a devastating ophthalmological emergency. Hong Kong Med J. 2015;21(5):475.e1–2. https://doi.org/10.12809/hkmj154526.
Matsuda S, Kirishima T, Okamoto N, Hisano Y, Takai K, Motoyoshi T, et al. Bacillus cereus septicemia and necrotizing fasciitis in a patient with liver cirrhosis: a case report. Nihon Shokakibyo Gakkai Zasshi. 2014;111(10):2013–20.
Kumar N, Garg N, Kumar N, Van Wagoner N. Bacillus cereus panophthalmitis associated with injection drug use. Int J Infect Dis. 2014;26:165–6. https://doi.org/10.1016/j.ijid.2014.01.019.
Hansford JR, Phillips M, Cole C, Francis J, Blyth CC, Gottardo NG. Bacillus cereus bacteremia and multiple brain abscesses during acute lymphoblastic leukemia induction therapy. J Pediatr Hematol Oncol. 2014;36(3):e197–201. https://doi.org/10.1097/MPH.0b013e31828e5455.
• Lotte R, Hérissé AL, Berrouane Y, Lotte L, Casagrande F, Landraud L, et al. Virulence analysis of Bacillus cereus isolated after death of preterm neonates, Nice, France, 2013. Emerg Infect Dis. 2017;23(5):845–8. https://doi.org/10.3201/eid2305.161788. This study provides comprehensive scientific data on the pathogenic potential of the B . cereus strains linked to severe infections.
Soudet S, Becquart C, Dezoteux F, Faure K, Staumont-Salle D, Delaporte E. Bacillus cereus endocarditis and a probable cutaneous gateway. Ann Dermatol Venereol. 2017;144(1):45–8. https://doi.org/10.1016/j.annder.2016.09.045.
Tatara R, Nagai T, Suzuki M, Oh I, Fujiwara S, Norizuki M, et al. Sepsis and meningoencephalitis caused by Bacillus cereus in a patient with myelodysplastic syndrome. Intern Med. 2013;52(17):1987–90.
Chou YL, Cheng SN, Hsieh KH, Wang CC, Chen SJ, Lo WT. Bacillus cereus septicemia in a patient with acute lymphoblastic leukemia: a case report and review of the literature. J Microbiol Immunol Infect. 2016;49(3):448–51. https://doi.org/10.1016/j.jmii.2013.06.010.
Rosenbaum A, Papaliodis D, Alley M, Lisella J, Flaherty M. Bacillus cereus fasciitis: a unique pathogen and clinically challenging sequela of inoculation. Am J Orthop (Belle Mead NJ). 2013;42(1):37–9.
Hegarty RM, Sanka S, Bansal S. Hepatic abscess: presentation in a previously healthy teenager. Arch Dis Child. 2013;98(2):145. https://doi.org/10.1136/archdischild-2012-303123.
Sohngen P, Blaise P, Duchesne B, Rakic JM. Clinical case of the month. Acute post-traumatic panophthalmitis. Rev Med Liege. 2012;67(9):449–51.
Barraud O, Hidri N, Ly K, Pichon N, Manea P, Ploy MC, et al. Pacemaker-associated Bacillus cereus endocarditis. Diagn Microbiol Infect Dis. 2012;74(3):313–5. https://doi.org/10.1016/j.diagmicrobio.2012.08.002.
Ngow HA, Wan Khairina WM. Bacillus cereus endocarditis in native aortic valve. J Infect Chemother. 2013;19(1):154–7. https://doi.org/10.1007/s10156-012-0427-2.
Kelley JM, Onderdonk AB, Kao G. Bacillus cereus septicemia attributed to a matched unrelated bone marrow transplant. Transfusion. 2013;53(2):394–7. https://doi.org/10.1111/j.1537-2995.2012.03723.x.
Basak SK, Deolekar SS, Mohanta A, Banerjee S, Saha S. Bacillus cereus infection after Descemet stripping endothelial keratoplasty. Cornea. 2012;31(9):1068–70. https://doi.org/10.1097/ICO.0b013e31823f0b49.
Hirabayashi K, Shiohara M, Suzuki T, Saito S, Tanaka M, Yanagisawa R, et al. Critical illness polyneuropathy and myopathy caused by Bacillus cereus sepsis in acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2012;34(3):e110–3. https://doi.org/10.1097/MPH.0b013e318234620b.
Frenzel E, Kranzler M, Stark TD, Hofmann T, Ehling-Schulz M. The endospore-forming pathogen Bacillus cereus exploits a small colony variant-based diversification strategy in response to aminoglycoside exposure. MBio. 2015;6(6):e01172–15. https://doi.org/10.1128/mBio.01172-15.
Funding
Open access funding provided by University of Veterinary Medicine Vienna.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Foodborne Pathogens
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Messelhäußer, U., Ehling-Schulz, M. Bacillus cereus—a Multifaceted Opportunistic Pathogen. Curr Clin Micro Rpt 5, 120–125 (2018). https://doi.org/10.1007/s40588-018-0095-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40588-018-0095-9